The research explores why patients’ engagement with medicines is often suboptimal, and why understanding behaviour is key to developing tailored and practical programmes.
This research explores what patients value most from their treatment and their key expectations for their treatment.
This research aims to gain insights on how the information or advice that Type 2 Diabetes patients are given impacts their decisions on how they manage their diabetes.
This research aims to explore how treatment expectations & priorities, treatment empowerment, and beliefs about medicines in MS relate to each other across 9 countries
This research aims to identify which health care professionals Type 2 Diabetes patients prefer to spend more time with and why.
MS-LIME: Longitudinal Insights into Patient Medication
This research is a longitudinal study which investigates the same profile group of Multiple Sclerosis patients to see what changes over time.